Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1981 2
1982 1
1984 1
1985 4
1987 1
1988 1
1989 2
1990 1
1991 2
1992 3
1993 1
1994 1
1997 3
1998 2
1999 2
2000 2
2001 1
2004 3
2005 7
2006 4
2007 2
2008 2
2009 3
2010 5
2011 9
2012 9
2013 4
2014 4
2015 8
2016 4
2017 3
2018 2
2019 4
2020 5
2021 3
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

104 results
Results by year
Filters applied: . Clear all
Page 1
Improved survival with MEK inhibition in BRAF-mutated melanoma.
Flaherty KT, Robert C, Hersey P, Nathan P, Garbe C, Milhem M, Demidov LV, Hassel JC, Rutkowski P, Mohr P, Dummer R, Trefzer U, Larkin JM, Utikal J, Dreno B, Nyakas M, Middleton MR, Becker JC, Casey M, Sherman LJ, Wu FS, Ouellet D, Martin AM, Patel K, Schadendorf D; METRIC Study Group. Flaherty KT, et al. Among authors: wu fs. N Engl J Med. 2012 Jul 12;367(2):107-14. doi: 10.1056/NEJMoa1203421. Epub 2012 Jun 4. N Engl J Med. 2012. PMID: 22663011 Free article. Clinical Trial.
Radiopharmaceuticals for Neuroendocrine Tumors.
Chin RI, Wu FS, Menda Y, Kim H. Chin RI, et al. Among authors: wu fs. Semin Radiat Oncol. 2021 Jan;31(1):60-70. doi: 10.1016/j.semradonc.2020.07.007. Semin Radiat Oncol. 2021. PMID: 33246637 Review.
104 results